Focused Wealth Management, Inc - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 89 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$0700
+133.3%
0.00%
Q4 2021$03000.0%0.00%
Q3 2021$03000.0%0.00%
Q2 2021$03000.0%0.00%
Q1 2021$0300
-40.0%
0.00%
Q4 2020$05000.0%0.00%
Q3 2020$05000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 734,477$441,0000.04%
GSA CAPITAL PARTNERS LLP 516,218$310,0000.03%
Game Plan Financial Advisors, LLC 27,216$16,0000.01%
MONECO Advisors, LLC 35,000$21,0000.01%
Purus Wealth Management, LLC 15,000$9,0000.01%
Renaissance Technologies 6,038,664$3,630,0000.01%
Qube Research & Technologies Ltd 540,878$325,0000.00%
D. E. Shaw & Co., Inc. 6,690,867$4,022,0000.00%
Cutter & CO Brokerage, Inc. 19,000$11,0000.00%
Van Hulzen Asset Management, LLC 18,200$11,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders